JDK, a company with a professional team equipped with specialized and interdisciplinary technical talents, has been focusing on the development of pharmaceutical intermediates and basic chemicals. The

JDK, a company with a professional team equipped with specialized and interdisciplinary technical talents, has been making waves in the pharmaceutical industry with its development of 4-Amino-2-Hydrox

. The renowned pharmaceutical company, JDK, has recently announced a breakthrough in the development of pharmaceutical intermediates with the successful creation of Ceftriaxone Sodium. This significa

JDK, a company with a professional team equipped with specialized and interdisciplinary technical talents, has recently made significant strides in the development of pharmaceutical intermediates and

JDK, a leading company in the field of pharmaceutical intermediates and basic chemicals, is pleased to announce the availability of 4-Hydroxyphenylacetic Acid, a key ingredient in the production of va

JDK Introduces New 4-Amino-3-Chlorophenol Pharmaceutical Intermediate As a leading company in the development of pharmaceutical intermediates and basic chemicals, JDK is proud to announce the introdu

Ciclopirox is a medication used to treat a variety of fungal infections, including athlete's foot, jock itch, and ringworm. It works by stopping the growth of fungus. Ciclopirox is known for its effec

JDK, a company with a dedicated team of specialized and interdisciplinary technical talents focusing on the development of pharmaceutical intermediates and basic chemicals, has recently announced the

In recent pharmaceutical news, a breakthrough has been made with the development of a new compound known as 2-Amino-5-bromopyridine. This compound has the potential to revolutionize the pharmaceutical

JDK, a company specializing in the development of pharmaceutical intermediates and basic chemicals, has recently announced the successful synthesis of a new chemical compound with the CAS No. 21962-45